If you suffer from rheumatoid arthritis, then the term of “daily grind” has probably become something of a literal phrase. The fact that rheumatoid arthritis is incurable likely makes that fact harder to swallow, with something such as sleeping to gentle movement becoming chronically painful. Injections to lubricate your joints have also decided to slip into your schedule, meaning a potentially lengthy wait at a clinic, hospital or specialist for something progressively eating away at your time.
What if you were told however that there was another way?
In the near future, a drug may be taken orally to reduce the painful effects of rheumatoid arthritis, following research done in India based around a molecule known as Tofacitinib. Having entered the final stages of tests, the 150 patients tested had reported satisfying results, paving a promising future for those suffering from the uncomfortable syndrome. Tofacitinib is an enzyme that works alongside your DNA to reduce inflamed parts of the body, as well as ensuring that the joints are working properly. Whilst it does not cure or repair the joints, it regulates and preserves the joints so that no further damage can be done.
In the form of a tiny tablet, the cause-and-effect of your condition is both combated and reduced in a shorter space of time and with a less amount of hassle.
As widespread research across the globe helps to evolve the understanding behind rheumatoid arthritis and its potential treatment, doctors are hopeful that the molecule may hopefully pave the way in treating other diseases and issues.
With such exciting news on the horizon, the stress and debilitation of rheumatoid arthritis is taking a step closer to problem-free relief, so that you can sit back, relax and nod off with that good book – or show off that you can everything is going to be just fine.
If you are curious about this method of treatment, please consult your doctor.
Comments are closed.